Treatment for Wet Age-Related Macular Degeneration. Research on macular degeneration Overview Sophie J. Bakri, M.D., Mayo Clinic in Rochester, Minnesota, discusses her recent research study: Visual and Anatomic Outcomes of Anti-VEGF Therapy in Exudative AMD and Vitreomacular Interface Disease. £170,000 Using induced pluripotent stem cells to investigate Best associated macular degeneration. While there are many causes of macular degeneration, including genetic abnormalities such as Stargardt disease, age-related macular degeneration (AMD or ARMD) is by far the most common type. AMD is a disease associated with aging that gradually destroys the sharp central vision needed for seeing objects clearly and for common daily tasks such as reading and driving. A retina with dry AMD. Back in 2017, Dan Roberts made up this sweet, little list he named “Hidden Thoughts of the Visually Impaired.” It’s easy to research and read about macular degeneration symptoms, but it’s much more difficult to comprehend what it’s actually… Macular degeneration is currently the leading cause of …

One of the most significant challenges facing eye and vision researchers is developing an effective treatment for dry age-related macular degeneration (AMD). Age-related macular degeneration, or AMD, is the leading cause of blindness in people 55 and older in developed countries. Age-related macular degeneration, commonly referred to as AMD, is a retinal degenerative disease that causes a progressive loss of central vision.
CERA’s Macular Research aims to improve understanding of the disease processes and treatment options for age-related macular degeneration (AMD). The condition can lead to significant loss of central vision. Early detection of age-related macular degeneration is critical so that sight can be saved. The following research projects are currently being funded by the Macular Society.

The type of age-related macular degeneration you have will determine the treatment options recommended by your eye specialist. In particular, our research focuses on determining risk factors for progression from early AMD to advanced, the genetics of AMD; environmental associations with AMD, and biomarkers of AMD. Macular degeneration is a disease associated with aging that gradually destroys sharp, central vision. Dr Amanda-Jayne Carr, University College London Institute of Ophthalmology.